Semin intervent Radiol 2013; 30(02): 141-150
DOI: 10.1055/s-0033-1342955
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Lung Cancer Ablation: Technologies and Techniques

Erica S. Alexander
1   Department of Diagnostic Imaging, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, Rhode Island
,
Damian E. Dupuy
1   Department of Diagnostic Imaging, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, Rhode Island
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
28. Mai 2013 (online)

Abstract

The incidence of lung cancers in 2012 is estimated to reach 226,160 new cases, with only a third of patients suitable surgical candidates. Tumor ablation has emerged as an important and efficacious treatment option for nonsurgical lung cancer patients. This localized minimally invasive therapy is best suited for small oligonodular lesions or favorably located metastatic tumors. Radiofrequency ablation has been in use for over a decade, and newer modalities including microwave ablation, cryoablation, and irreversible electroporation have emerged as additional treatment options for patients. Ablation therapies can offer patients and clinicians a repeatable and effective therapy for palliation and, in some cases, cure of thoracic malignancies. This article discusses the available technologies and techniques available for tumor ablation of thoracic malignancies including patient selection, basic aspects of procedure technique, imaging follow-up, treatment outcomes, and comparisons between various therapies.

 
  • References

  • 1 American Cancer Society. Cancer facts and figures 2012. Atlanta, GA: American Cancer Society; 2012
  • 2 Rusch VW. Lung metastasis. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG, , eds. Clinical Oncology. 4th ed. Philadelphia, PA: Churchill Livingston; 2008: 873-884
  • 3 Robinson LA, Ruckdeschel JC, Wagner Jr H, Stevens CW. American College of Chest Physicians. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132 (3, Suppl): 243S-265S
  • 4 Ruckdeschel JC, Schwarz AG, Bepler G , et al. Cancer of the lung—NSCLC and SCLC. In: Abeloff MD, Armitage JO, Niederhuber JE, , eds. Abeloff's Clinical Oncology. 4th ed. Philadelphia, PA: Elsevier; 2008: 1649-1743
  • 5 Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg 2010; 211 (1) 68-72
  • 6 Pennathur A, Abbas G, Gooding WE , et al. Image-guided radiofrequency ablation of lung neoplasm in 100 consecutive patients by a thoracic surgical service. Ann Thorac Surg 2009; 88 (5) 1601-1606 ; discussion 1607–1608
  • 7 Simon CJ, Dupuy DE, DiPetrillo TA , et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 2007; 243 (1) 268-275
  • 8 de Baère T, Palussière J, Aupérin A , et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 2006; 240 (2) 587-596
  • 9 Lencioni R, Crocetti L, Cioni R , et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008; 9 (7) 621-628
  • 10 Kong FM, Ten Haken RK, Schipper MJ , et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 2005; 63 (2) 324-333
  • 11 Sura S, Yorke E, Jackson A, Rosenzweig KE. High-dose radiotherapy for the treatment of inoperable non-small cell lung cancer. Cancer J 2007; 13 (4) 238-242
  • 12 Bogart JA, Hodgson L, Seagren SL , et al. Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904. J Clin Oncol 2010; 28 (2) 202-206
  • 13 Onishi H, Shirato H, Nagata Y , et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007; 2 (7) (Suppl. 03) S94-S100
  • 14 Timmerman R, Paulus R, Galvin J , et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010; 303 (11) 1070-1076
  • 15 Jain SK, Dupuy DE, Cardarelli GA, Zheng Z, DiPetrillo TA. Percutaneous radiofrequency ablation of pulmonary malignancies: combined treatment with brachytherapy. AJR Am J Roentgenol 2003; 181 (3) 711-715
  • 16 Dupuy DE, Mayo-Smith WW, Abbott GF, DiPetrillo TA. Clinical applications of radio-frequency tumor ablation in the thorax. Radiographics 2002; 22 (Spec No) S259-S269
  • 17 McTaggart RA, Dupuy DE, Dipetrillo T. Image guided ablation in the thorax. In: Geschwind J-FH, Soulen MC, , eds. Interventional Oncology: Principles and Practice. New York, NY: Cambridge University Press; 2008: 440-474
  • 18 Suh R, Reckamp K, Zeidler M, Cameron R. Radiofrequency ablation in lung cancer: promising results in safety and efficacy. Oncology (Williston Park) 2005; 19 (11) (Suppl. 04) 12-21
  • 19 Alexander ES, Healey TT, Martin DW, Dupuy DE. Use of endobronchial valves for the treatment of bronchopleural fistulas after thermal ablation of lung neoplasms. J Vasc Interv Radiol 2012; 23 (9) 1236-1240
  • 20 VanSonnenberg E, Shankar S, Morrison PR , et al. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience—technical and multidisciplinary considerations in 30 patients. AJR Am J Roentgenol 2005; 184 (2) 381-390
  • 21 Kawamura M, Izumi Y, Tsukada N , et al. Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates. J Thorac Cardiovasc Surg 2006; 131 (5) 1007-1013
  • 22 Solomon SB, Thornton RH, Dupuy DE, Downey RJ. Protection of the mediastinum and chest wall with an artificial pneumothorax during lung ablations. J Vasc Interv Radiol 2008; 19 (4) 610-615
  • 23 Dupuy DE, Mayo-Smith WW, Abbott GF, DiPetrillo T. Clinical applications of radio-frequency tumor ablation in the thorax. Radiographics 2002; 22 (Spec No) S259-S269
  • 24 Nahum Goldberg S, Dupuy DE. Image-guided radiofrequency tumor ablation: challenges and opportunities—part I. J Vasc Interv Radiol 2001; 12 (9) 1021-1032
  • 25 Beland MD, Dupuy DE. Current and future applications of percutaneous radiofrequency ablation in the treatment of lung neoplasms. Appl Radiol 2006; 35 (12) 21-28
  • 26 Feng W, Liu W, Li C , et al. Percutaneous microwave coagulation therapy for lung cancer. Zhonghua Zhong Liu Za Zhi 2002; 24 (4) 388-390
  • 27 Wolf FJ, Grand DJ, Machan JT, Dipetrillo TA, Mayo-Smith WW, Dupuy DE. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology 2008; 247 (3) 871-879
  • 28 Lu Q, Cao W, Huang L , et al. CT-guided percutaneous microwave ablation of pulmonary malignancies: results in 69 cases. World J Surg Oncol 2012; 10: 80
  • 29 Belfiore G, Ronza F, Belfiore MP , et al. Patients' survival in lung malignancies treated by microwave ablation: our experience on 56 patients. Eur J Radiol 2013; 82 (1) 177-181
  • 30 Gage AA, Baust JG. Mechanisms of tissue injury in cryosurgery. Cryobiology 1998; 37 (3) 171-186
  • 31 Izumi Y, Oyama T, Ikeda E, Kawamura M, Kobayashi K. The acute effects of transthoracic cryoablation on normal lung evaluated in a porcine model. Ann Thorac Surg 2005; 79 (1) 318-322 ; discussion 322
  • 32 Hinshaw JL, Lee Jr FT, Laeseke PF, Sampson LA, Brace C. Temperature isotherms during pulmonary cryoablation and their correlation with the zone of ablation. J Vasc Interv Radiol 2010; 21 (9) 1424-1428
  • 33 Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005; 33 (2) 223-231
  • 34 Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, Kee ST. Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology 2010; 255 (2) 426-433
  • 35 Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality—clinical implications. Technol Cancer Res Treat 2007; 6 (1) 37-48
  • 36 Rempp H, Boss A, Helmberger T, Pereira P. The current role of minimally invasive therapies in the management of liver tumors. Abdom Imaging 2011; 36 (6) 635-647
  • 37 McTaggart RA, Dupuy DE. Thermal ablation of lung tumors. Tech Vasc Interv Radiol 2007; 10 (2) 102-113
  • 38 Dupuy DE, Aswad B, Ng T. Irreversible electroporation in a swine lung model. Cardiovasc Intervent Radiol 2011; 34 (2) 391-395
  • 39 Mali B, Jarm T, Corovic S , et al. The effect of electroporation pulses on functioning of the heart. Med Biol Eng Comput 2008; 46 (8) 745-757
  • 40 Grieco CA, Simon CJ, Mayo-Smith WW, Dipetrillo TA, Ready NE, Dupuy DE. Image-guided percutaneous thermal ablation for the palliative treatment of chest wall masses. Am J Clin Oncol 2007; 30 (4) 361-367
  • 41 Suh RD, Wallace AB, Sheehan RE, Heinze SB, Goldin JG. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation—preliminary results. Radiology 2003; 229 (3) 821-829
  • 42 Gadaleta C, Mattioli V, Colucci G , et al. Radiofrequency ablation of 40 lung neoplasms: preliminary results. AJR Am J Roentgenol 2004; 183 (2) 361-368
  • 43 Steinke K, King J, Glenn D, Morris DL. Radiologic appearance and complications of percutaneous computed tomography-guided radiofrequency-ablated pulmonary metastases from colorectal carcinoma. J Comput Assist Tomogr 2003; 27 (5) 750-757
  • 44 Jin GY, Lee JM, Lee YC, Han YM, Lim YS. Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT. AJR Am J Roentgenol 2004; 183 (4) 1013-1020
  • 45 Swensen SJ, Viggiano RW, Midthun DE , et al. Lung nodule enhancement at CT: multicenter study. Radiology 2000; 214 (1) 73-80
  • 46 Yoo DC, Dupuy DE, Hillman SL , et al. Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome?. AJR Am J Roentgenol 2011; 197 (2) 334-340
  • 47 Brace CL, Hinshaw JL, Laeseke PF, Sampson LA, Lee Jr FT. Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model. Radiology 2009; 251 (3) 705-711
  • 48 Dupuy DE. Microwave ablation compared with radiofrequency ablation in lung tissue—is microwave not just for popcorn anymore?. Radiology 2009; 251 (3) 617-618
  • 49 Goldberg SN, Gazelle GS, Solbiati L, Rittman WJ, Mueller PR. Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad Radiol 1996; 3 (8) 636-644
  • 50 Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics 2005; 25 (Suppl. 01) S69-S83
  • 51 Yu NC, Lu DS, Raman SS , et al. Hepatocellular carcinoma: microwave ablation with multiple straight and loop antenna clusters—pilot comparison with pathologic findings. Radiology 2006; 239 (1) 269-275
  • 52 Maiwand MO. The role of cryosurgery in palliation of tracheo-bronchial carcinoma. Eur J Cardiothorac Surg 1999; 15 (6) 764-768
  • 53 Maiwand MO, Homasson JP. Cryotherapy for tracheobronchial disorders. Clin Chest Med 1995; 16 (3) 427-443
  • 54 Sanderson DR, Neel III HB, Fontana RS. Bronchoscopic cryotherapy. Ann Otol Rhinol Laryngol 1981; 90 (4 Pt 1) 354-358
  • 55 Wang H, Littrup PJ, Duan Y, Zhang Y, Feng H, Nie Z. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology 2005; 235 (1) 289-298
  • 56 Thomson KR, Cheung W, Ellis SJ , et al. Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol 2011; 22 (5) 611-621